Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/7953
Title: Physical birth outcomes in neonates prenatally exposed to buprenorphine – our first experiences
Authors: Natasha Simonovska 
Beti Zafirova-Ivanovska 
Aleksandra Babulovska 
Keywords: buprenorphine
pregnancy
neonates
physical birth outcomes
Issue Date: 17-Sep-2019
Journal: Srpski Arhiv za Celokupno Lekarstvo
Abstract: Introduction/Objective Buprenorphine appears generally similar to, and in some cases superior to, methadone in terms of maternal, fetal, and neonatal outcomes. The objective of the study was to assess some physical birth outcomes in neonates prenatally exposed to buprenorphine. Methods During a seven-year period, nine patients have been treated with buprenorphine during their pregnancy. All women underwent interview, clinical investigations, biochemical analysis, toxicological screening, viral markers for hepatitis B, C, HIV, with regular check-ups by an obstetrician and a psychiatrist. Newborn outcomes included: birth weight in grams, birth length in centimeters, physical anomalies, head/chest circumference in centimeters, Apgar score at 1 minute / 5 minutes, gestational age (weeks), newborn length of hospital stay in days, breast-feeding, the newborn’s need for pharmacologic treat￾ment after delivery. Results The mean birth weight was 2,991.11 ± 37 g; birth length was 49.44 ± 2.29 cm; head circumference was 33.11 ± 0.78 cm; chest circumference was 32.33 ± 1 cm; first minute Apgar score was 8.22, fifth minute 9.22; age at delivery was 38.77 ± 1.09 weeks; hospitalization after delivery 4.44 ± 1.13 days. None of the newborns had physical anomalies. Six of the newborns were breastfed. Conclusion Buprenorphine is a safe and important part of a complete comprehensive treatment approach in pregnant women with opioid use disorder. Buprenorphine treatment of maternal opioid use disorder indicated a low risk of preterm birth, normal birth weight and length, head and chest circumference, Apgar score, short hospitalization after delivery.
URI: http://hdl.handle.net/20.500.12188/7953
DOI: https://doi.org/10.2298/SARH171213105S
Appears in Collections:Faculty of Medicine: Journal Articles

Files in This Item:
File Description SizeFormat 
Buprenorfin cjelokupno ljekarstvo 2019.pdf162.15 kBAdobe PDFThumbnail
View/Open
Show full item record

Page view(s)

110
checked on Apr 19, 2024

Download(s)

20
checked on Apr 19, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.